The landscape of dementia diagnosis has developed considerably with the appearance of subtle biomarkers, including amyloid PET scans, tau imaging, and blood-primarily based tests that may detect Alzheimer's pathology many years before indications arise. Even though these technological developments represent extraordinary development in knowing neurodegenerative illnesses, they have no... https://bertoltu986aku6.theblogfairy.com/profile